Bank of America upgraded shares of Core Laboratories (NYSE:CLB) from a neutral rating to a buy rating in a research report report published on Wednesday, 24/7 WallStreet reports. Bank of America currently has $63.00 price target on the oil and gas company’s stock.

Other equities analysts have also recently issued reports about the company. Zacks Investment Research cut Heritage Insurance from a hold rating to a strong sell rating in a report on Friday, April 26th. Royal Bank of Canada reaffirmed an underperform rating and issued a GBX 215 ($2.81) target price on shares of in a report on Wednesday, June 26th. Piper Jaffray Companies set a $52.00 target price on Core Laboratories and gave the stock a hold rating in a report on Wednesday, June 26th. Finally, Stifel Nicolaus reaffirmed a buy rating and issued a $170.00 target price on shares of Spotify in a report on Friday, April 26th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the company. The stock currently has a consensus rating of Hold and an average target price of $78.58.

Core Laboratories stock traded up $1.16 during trading on Wednesday, reaching $55.00. The company had a trading volume of 1,204,100 shares, compared to its average volume of 606,209. Core Laboratories has a 52 week low of $46.32 and a 52 week high of $122.11. The business’s 50-day moving average is $50.96. The stock has a market capitalization of $2.39 billion, a price-to-earnings ratio of 24.12, a price-to-earnings-growth ratio of 2.81 and a beta of 1.93. The company has a debt-to-equity ratio of 1.92, a current ratio of 1.84 and a quick ratio of 1.45.

Core Laboratories (NYSE:CLB) last announced its earnings results on Wednesday, April 24th. The oil and gas company reported $0.44 EPS for the quarter, topping the Zacks’ consensus estimate of $0.43 by $0.01. Core Laboratories had a return on equity of 57.13% and a net margin of 13.79%. The company had revenue of $169.19 million for the quarter, compared to analysts’ expectations of $166.79 million. During the same period last year, the firm earned $0.57 EPS. Core Laboratories’s revenue for the quarter was down .5% compared to the same quarter last year. On average, sell-side analysts forecast that Core Laboratories will post 1.95 EPS for the current year.

Large investors have recently bought and sold shares of the business. Marshall Wace LLP bought a new stake in Core Laboratories during the first quarter valued at about $30,000. Bremer Bank National Association bought a new stake in Core Laboratories during the first quarter valued at about $30,000. Quadrant Capital Group LLC raised its holdings in Core Laboratories by 408.0% during the first quarter. Quadrant Capital Group LLC now owns 884 shares of the oil and gas company’s stock valued at $59,000 after acquiring an additional 710 shares during the period. Financial Gravity Wealth Inc. bought a new stake in Core Laboratories during the first quarter valued at about $75,000. Finally, Captrust Financial Advisors raised its holdings in Core Laboratories by 20.4% during the fourth quarter. Captrust Financial Advisors now owns 1,856 shares of the oil and gas company’s stock valued at $111,000 after acquiring an additional 314 shares during the period.

About Core Laboratories

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.

See Also: How does a security become overbought?

Analyst Recommendations for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.